An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Evolving Treatment Options for Low-Risk Myelodysplastic Syndromes 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Fertility Preservation in Hematologic Malignancies: Navigating Complex Choices 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Management of High-Risk Acute Promyelocytic Leukemia in the Community Setting 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Optimizing Cytoreductive Therapy for Polycythemia Vera 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Recorded Presentations from the NCCN 2025 Annual Congress: Hematologic Malignancies™ 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Comprehensive Care for Adult Survivors of Hematologic Malignancies 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
The Role of Minimal Residual Disease in Hematologic Malignancies 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Monitoring Toxicities in the Ambulatory Setting 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Evolving Treatment Strategies for Acute Myeloid Leukemia 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Emerging Treatment Strategies for High-Risk Myelodysplastic Syndromes 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Incorporating TKIs in the Treatment of Myelofibrosis 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Integrating New Therapies for the Treatment of Chronic Phase Chronic Myeloid Leukemia 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Role of Allogeneic Transplants in Acute Lymphoblastic Leukemia 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Deploying Novel Therapies for Acute Lymphoblastic Leukemia 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Optimizing Patient Care Coordination Between Academic and Community Settings 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm

Pages